GH Research PLC (GHRS)
11.65
+0.45
(+4.02%)
USD |
NASDAQ |
Jun 01, 16:00
11.63
-0.02
(-0.17%)
After-Hours: 20:00
GH Research Enterprise Value: 443.22M for June 1, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 01, 2023 | 443.22M |
| May 31, 2023 | 419.81M |
| May 30, 2023 | 404.21M |
| May 26, 2023 | 409.41M |
| May 25, 2023 | 419.81M |
| May 24, 2023 | 413.05M |
| May 23, 2023 | 416.69M |
| May 22, 2023 | 404.73M |
| May 19, 2023 | 409.41M |
| May 18, 2023 | 390.68M |
| May 17, 2023 | 412.53M |
| May 16, 2023 | 383.40M |
| May 15, 2023 | 404.21M |
| May 12, 2023 | 390.16M |
| May 11, 2023 | 366.23M |
| May 10, 2023 | 348.02M |
| May 09, 2023 | 305.37M |
| May 08, 2023 | 300.68M |
| May 05, 2023 | 307.97M |
| May 04, 2023 | 289.24M |
| May 03, 2023 | 279.36M |
| May 02, 2023 | 301.20M |
| May 01, 2023 | 305.37M |
| April 28, 2023 | 274.15M |
| April 27, 2023 | 273.11M |
| Date | Value |
|---|---|
| April 26, 2023 | 251.78M |
| April 25, 2023 | 248.14M |
| April 24, 2023 | 261.67M |
| April 21, 2023 | 250.74M |
| April 20, 2023 | 263.23M |
| April 19, 2023 | 274.15M |
| April 18, 2023 | 275.71M |
| April 17, 2023 | 271.03M |
| April 14, 2023 | 256.47M |
| April 13, 2023 | 265.31M |
| April 12, 2023 | 279.36M |
| April 11, 2023 | 257.51M |
| April 10, 2023 | 273.11M |
| April 06, 2023 | 281.96M |
| April 05, 2023 | 268.95M |
| April 04, 2023 | 249.18M |
| April 03, 2023 | 247.10M |
| March 31, 2023 | 252.83M |
| March 30, 2023 | 258.01M |
| March 29, 2023 | 250.21M |
| March 28, 2023 | 223.68M |
| March 27, 2023 | 229.40M |
| March 24, 2023 | 246.57M |
| March 23, 2023 | 193.51M |
| March 22, 2023 | 147.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
147.21M
Minimum
Mar 22 2023
1.171B
Maximum
Nov 09 2021
513.77M
Average
413.05M
Median
May 24 2023
Enterprise Value Benchmarks
| Jazz Pharmaceuticals PLC | 12.82B |
| Prothena Corp PLC | 2.816B |
| Nabriva Therapeutics PLC | 3.962M |
| Iterum Therapeutics PLC | -6.286M |
| Mallinckrodt PLC | 2.640B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.94M |
| Total Expenses (Quarterly) | 10.62M |
| EPS Diluted (Quarterly) | -0.21 |
| Earnings Yield | -4.56% |